Cargando…
Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
By May 30, 2022, there were 526,182,662 confirmed COVID- 19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the populat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365642/ https://www.ncbi.nlm.nih.gov/pubmed/37492424 http://dx.doi.org/10.4081/jphia.2023.2290 |
_version_ | 1785077037336100864 |
---|---|
author | Eguavoen, Amenze Larson, Heidi J Chinye-Nwoko, Fejiro Ojeniyi, Toluwanimi |
author_facet | Eguavoen, Amenze Larson, Heidi J Chinye-Nwoko, Fejiro Ojeniyi, Toluwanimi |
author_sort | Eguavoen, Amenze |
collection | PubMed |
description | By May 30, 2022, there were 526,182,662 confirmed COVID- 19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the population; however, only 27.4 million people (13.3% of the population) had received at least one dose of the vaccine. This article examines available evidence on COVID-19 vaccine hesitancy in Nigeria and makes recommendations for improving its uptake. Major causes of COVID-19 vaccine hesitancy identified in Nigeria were concerns around vaccine efficacy and safety, disbelief in the existence and severity of the disease, and distrust of the government. To reduce COVID-19 vaccine hesitancy and improve vaccine coverage in Nigeria, mapping vaccine acceptance and hesitancy across geographies and demographics is needed, as well as increased stakeholder communication, and effective community engagement. |
format | Online Article Text |
id | pubmed-10365642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-103656422023-07-25 Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria Eguavoen, Amenze Larson, Heidi J Chinye-Nwoko, Fejiro Ojeniyi, Toluwanimi J Public Health Afr Article By May 30, 2022, there were 526,182,662 confirmed COVID- 19 cases and 6,286,057 deaths globally; of which Nigeria had recorded 256,028 confirmed cases and 3143 deaths. By the same time, Nigeria had received a total of 93.9 million doses of the COVID-19 vaccine, enough to vaccinate 25% of the population; however, only 27.4 million people (13.3% of the population) had received at least one dose of the vaccine. This article examines available evidence on COVID-19 vaccine hesitancy in Nigeria and makes recommendations for improving its uptake. Major causes of COVID-19 vaccine hesitancy identified in Nigeria were concerns around vaccine efficacy and safety, disbelief in the existence and severity of the disease, and distrust of the government. To reduce COVID-19 vaccine hesitancy and improve vaccine coverage in Nigeria, mapping vaccine acceptance and hesitancy across geographies and demographics is needed, as well as increased stakeholder communication, and effective community engagement. PAGEPress Publications, Pavia, Italy 2023-05-04 /pmc/articles/PMC10365642/ /pubmed/37492424 http://dx.doi.org/10.4081/jphia.2023.2290 Text en ©Copyright: the Author(s), https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Eguavoen, Amenze Larson, Heidi J Chinye-Nwoko, Fejiro Ojeniyi, Toluwanimi Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria |
title | Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria |
title_full | Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria |
title_fullStr | Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria |
title_full_unstemmed | Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria |
title_short | Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria |
title_sort | reducing covid-19 vaccine hesitancy and improving vaccine uptake in nigeria |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365642/ https://www.ncbi.nlm.nih.gov/pubmed/37492424 http://dx.doi.org/10.4081/jphia.2023.2290 |
work_keys_str_mv | AT eguavoenamenze reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria AT larsonheidij reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria AT chinyenwokofejiro reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria AT ojeniyitoluwanimi reducingcovid19vaccinehesitancyandimprovingvaccineuptakeinnigeria |